← Back to Search

Behavioral Intervention

Digital Coaching for Smoking Cessation (TAMI Trial)

N/A

Waitlist Available

Led By Jason Satterfield, PhD

Research Sponsored by University of California, San Francisco

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Age 18 or older

Be older than 18 years old

Must not have

Current use of Nicotine Replacement Therapy or smoking cessation pharmacotherapy

Cognitive impairment that would preclude informed consent

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, 3-month, 6-month

Awards & highlights

No Placebo-Only Group

Summary

"This trial aims to test a digital coaching program that uses a chatbot to help people quit smoking by providing motivation, education, and personalized quit plans to overcome social barriers."

Who is the study for?

This trial is for individuals who are currently smoking and interested in quitting. They should be willing to engage with a digital coach via chatbot to increase their motivation and create a personalized plan to stop smoking. The details about specific inclusion or exclusion criteria are not provided.

What is being tested?

The study tests a Technology Assisted Motivational Interviewing (TAMI) Coach, which is a chatbot designed to help smokers quit by boosting their readiness to change, educating them on cessation tools in multiple languages, and helping develop tailored plans that consider social barriers.

What are the potential side effects?

Since this intervention involves motivational interviewing through technology rather than medication or medical procedures, traditional side effects are not applicable. Participants may experience psychological discomfort if the discussions trigger stress related to quitting.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I am currently using methods or medications to help me stop smoking.

Select...

I am able to understand and give informed consent.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, 3-month, 6-month

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, 3-month, 6-month

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 3-month, 6-month for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Biochemical verification of smoking abstinence

Secondary study objectives

AHC Screening Tool

Bayliss Disease Burden

Chatbot engagement and usage

+8 more

Other study objectives

Demographics

Treatment barriers/facilitators

User experience and satisfaction

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Technology Assisted Motivational Interviewing (TAMI)Experimental Treatment1 Intervention

Individuals randomized to TAMI will interact with the fully automated, web-based MI-chatbot for the 6-month study period. Patients who continue to smoke will receive up to two text messages per week with the chatbot URL link to initiate additional conversations always beginning with an assessment of readiness to change but "remembering" prior conversations much like a clinician. Individuals in the preparation stage will move directly to EBP education, tailoring a quit plan and boosting both self-efficacy and outcome expectancies. Patients with sufficient confidence will be encouraged to set a quit date. Patients will be encouraged to include their PCP and/or state quitline. TAMI will provide support proximal to the quit date including guidance through common obstacles. TAMI will check back to assess treatment initiation, treatment sustainment (and/or cessation), or relapse. Patients who are unable to quit (or who relapse) will be encouraged to restart conversations with TAMI.

Group II: Usual CareActive Control1 Intervention

Individuals randomized to the Usual Care (UC) condition will receive a detailed educational handout on the health risks associated with smoking and information on Evidence Based Practice's (EBP) for cessation using the standard "Kick-It California" materials. Additional materials and referral resources regarding depression, stress, and other common barriers will be provided to all UC participants. Any UC individual can choose to quit at any time but they will not have access to TAMI. While this is not an "active" treatment condition, the handout and recurring assessments (at 3 and 6mo) may serve as reminders about the importance of quitting and may assist with finding support for co-occurring conditions or social needs.

0 / 3Eligibility criteria met